HIMS higher RR Hello,
Technical prespective only:
Equal Low of the Bullish Breaker, as long it holds the channel is valid and we could see higher prices towards the algotargets (red), if the price dips then i'll be adding more to the bag.
NFA
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.58 USD
126.04 M USD
1.48 B USD
182.08 M
About Hims & Hers Health, Inc.
Sector
Industry
CEO
Andrew Dudum
Website
Headquarters
San Francisco
Founded
2017
FIGI
BBG00Q53VYM7
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
No news here
Looks like there's nothing to report right now
Selling Options On Hims & Hers Could Yield 20% Or MoreAfter recommending Hims & Hers NYSE:HIMS as a 'Strong Buy' from $6, we recently downgraded it due to its stretched valuation. Since then, the stock has dropped over 40%, but we don't yet see it as a clear value proposition at current levels.
HIMS combines two critical elements:
- High lifetime cu
45$I know they have some issues with the glp1 one stuff but revenues are strong and this won't matter long term I think everyone knows that. They'll beat earnings next week and we're headed to 35 range I grabbed a bunch of cheap 45 7/18 calls along with some 40 41s. 31% short Interest right now I'm sur
HIMS: how I charted this + bullish/bearish/neutral scenarios! Bullish
A break and hold above the 20EMA would shift momentum back to the upside.
Initial resistance would be around 30, where previous price congestion sits.
If buyers can push through, next target would be around 35–36, near the declining 50SMA.
There is a short-term intraday trendline form
Quantum's HIMS Trading Guide 4/10/25 HIMS (Hims & Hers Health, Inc.) - Sector: Healthcare (Telehealth)
Sentiment: Bullish. Post-close call volume steady, RSI ~58 (up from ~55), Amplified GLP-1 demand—speculation persists despite tariff noise.
Tariff Impact: Minimal. Domestic focus shields HIMS; 104% China tariffs irrelevant unless g
Safe and Confident Entry ZoneStock reached resistance and rejected with fake break-out.
The stock targeting the green 4h zone.
Note: Potentional of Strong Buying Zone:
We have two scenarios must happen at The Mentioned Zone:
Scenarios One: strong buying volume with reversal Candle.
Scenarios Two: Fake Break-Out of The Buyin
HIMS – 30-Min Long Setup!📈
🔹 Ticker: HIMS (NYSE)
🔹 Timeframe: 30-Min
🔹 Setup Type: Falling Trendline Break + Support Bounce
🔸 Price at Breakout: ~$29.55
📊 Trade Plan (Long Position)
✅ Entry Zone: $29.50–$30.00 (breakout above yellow zone + trendline break)
✅ Stop Loss (SL): Below $28.50 (white support line & structure low)
Hims buying opportunity comingPrice action looks like it wants to test support levels much lower than this. Around $32-$28 would be a good area to add if you're looking to get more into hims stock. I have a pretty large position and would only be interested if we get the the lower green support levels. If not, let it ride.
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HIMS is 33.10 USD — it has increased by 23.03% in the past 24 hours. Watch Hims & Hers Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Hims & Hers Health, Inc. stocks are traded under the ticker HIMS.
HIMS stock has risen by 32.28% compared to the previous week, the month change is a 10.92% rise, over the last year Hims & Hers Health, Inc. has showed a 167.15% increase.
We've gathered analysts' opinions on Hims & Hers Health, Inc. future price: according to them, HIMS price has a max estimate of 85.00 USD and a min estimate of 25.00 USD. Watch HIMS chart and read a more detailed Hims & Hers Health, Inc. stock forecast: see what analysts think of Hims & Hers Health, Inc. and suggest that you do with its stocks.
HIMS reached its all-time high on Feb 19, 2025 with the price of 72.98 USD, and its all-time low was 2.72 USD and was reached on May 12, 2022. View more price dynamics on HIMS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HIMS stock is 10.36% volatile and has beta coefficient of 2.90. Track Hims & Hers Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Hims & Hers Health, Inc. there?
Today Hims & Hers Health, Inc. has the market capitalization of 7.78 B, it has increased by 12.35% over the last week.
Yes, you can track Hims & Hers Health, Inc. financials in yearly and quarterly reports right on TradingView.
Hims & Hers Health, Inc. is going to release the next earnings report on May 5, 2025. Keep track of upcoming events with our Earnings Calendar.
HIMS earnings for the last quarter are 0.11 USD per share, whereas the estimation was 0.11 USD resulting in a −2.94% surprise. The estimated earnings for the next quarter are 0.12 USD per share. See more details about Hims & Hers Health, Inc. earnings.
Hims & Hers Health, Inc. revenue for the last quarter amounts to 481.14 M USD, despite the estimated figure of 470.85 M USD. In the next quarter, revenue is expected to reach 538.18 M USD.
HIMS net income for the last quarter is 26.02 M USD, while the quarter before that showed 75.59 M USD of net income which accounts for −65.57% change. Track more Hims & Hers Health, Inc. financial stats to get the full picture.
No, HIMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 30, 2025, the company has 1.64 K employees. See our rating of the largest employees — is Hims & Hers Health, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hims & Hers Health, Inc. EBITDA is 85.09 M USD, and current EBITDA margin is 5.76%. See more stats in Hims & Hers Health, Inc. financial statements.
Like other stocks, HIMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hims & Hers Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hims & Hers Health, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hims & Hers Health, Inc. stock shows the buy signal. See more of Hims & Hers Health, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.